Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acinetobacter Infections | 1 | 2015 | 73 | 0.490 |
Why?
|
| Carbapenems | 1 | 2015 | 125 | 0.470 |
Why?
|
| Acinetobacter baumannii | 1 | 2015 | 123 | 0.460 |
Why?
|
| Midazolam | 5 | 2001 | 267 | 0.420 |
Why?
|
| Atracurium | 2 | 2008 | 51 | 0.410 |
Why?
|
| Prilocaine | 1 | 2010 | 20 | 0.350 |
Why?
|
| Tetracaine | 1 | 2010 | 34 | 0.350 |
Why?
|
| Hysterectomy, Vaginal | 2 | 2008 | 28 | 0.340 |
Why?
|
| Phlebotomy | 1 | 2010 | 138 | 0.330 |
Why?
|
| Anesthetics, Local | 2 | 2010 | 1005 | 0.320 |
Why?
|
| Hemodynamics | 9 | 2001 | 4186 | 0.310 |
Why?
|
| Dipyrone | 1 | 2008 | 9 | 0.300 |
Why?
|
| Anesthesia, Local | 1 | 2010 | 277 | 0.290 |
Why?
|
| Hypertonic Solutions | 1 | 2007 | 82 | 0.290 |
Why?
|
| Prednisolone | 1 | 2008 | 326 | 0.280 |
Why?
|
| Lidocaine | 1 | 2010 | 545 | 0.270 |
Why?
|
| Oxidants | 1 | 2007 | 168 | 0.270 |
Why?
|
| Leukocyte Elastase | 1 | 2007 | 113 | 0.270 |
Why?
|
| Isoxazoles | 1 | 2008 | 233 | 0.260 |
Why?
|
| Superoxides | 1 | 2007 | 388 | 0.260 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 1761 | 0.260 |
Why?
|
| Neuromuscular Junction | 1 | 2008 | 399 | 0.250 |
Why?
|
| Pain, Postoperative | 3 | 2008 | 1768 | 0.250 |
Why?
|
| Anesthesia, Intravenous | 2 | 1996 | 130 | 0.230 |
Why?
|
| Bupivacaine | 2 | 2000 | 414 | 0.220 |
Why?
|
| Enoximone | 2 | 1993 | 9 | 0.220 |
Why?
|
| Coronary Artery Bypass | 3 | 2007 | 2189 | 0.220 |
Why?
|
| Halothane | 2 | 1993 | 200 | 0.210 |
Why?
|
| Isoflurane | 3 | 2002 | 383 | 0.210 |
Why?
|
| Capnography | 1 | 2003 | 90 | 0.210 |
Why?
|
| Anesthesia, Inhalation | 2 | 1993 | 220 | 0.200 |
Why?
|
| Intensive Care Units | 1 | 2015 | 3797 | 0.200 |
Why?
|
| Propofol | 2 | 2001 | 608 | 0.190 |
Why?
|
| Sufentanil | 1 | 2001 | 42 | 0.190 |
Why?
|
| Anesthetics, Combined | 1 | 2001 | 43 | 0.190 |
Why?
|
| Sotalol | 1 | 1999 | 47 | 0.170 |
Why?
|
| Cardiac Output | 4 | 2007 | 837 | 0.170 |
Why?
|
| Emergency Treatment | 1 | 2003 | 495 | 0.170 |
Why?
|
| Episiotomy | 1 | 1999 | 21 | 0.160 |
Why?
|
| Glucocorticoids | 1 | 2008 | 2163 | 0.150 |
Why?
|
| Thoracotomy | 1 | 2000 | 374 | 0.150 |
Why?
|
| Tachycardia | 1 | 1999 | 598 | 0.140 |
Why?
|
| Analgesia, Patient-Controlled | 3 | 2008 | 117 | 0.140 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 7469 | 0.140 |
Why?
|
| Conscious Sedation | 1 | 2001 | 534 | 0.130 |
Why?
|
| Short Bowel Syndrome | 1 | 1999 | 352 | 0.130 |
Why?
|
| Piperidines | 2 | 2002 | 1667 | 0.130 |
Why?
|
| Preanesthetic Medication | 3 | 2002 | 48 | 0.130 |
Why?
|
| Puerperal Disorders | 1 | 1999 | 304 | 0.130 |
Why?
|
| Anesthesia Recovery Period | 3 | 2008 | 155 | 0.130 |
Why?
|
| Analgesia | 1 | 2000 | 461 | 0.130 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1999 | 773 | 0.120 |
Why?
|
| beta-Lactam Resistance | 1 | 2015 | 79 | 0.120 |
Why?
|
| Pirinitramide | 2 | 2008 | 3 | 0.120 |
Why?
|
| Escherichia coli Infections | 1 | 1999 | 518 | 0.120 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2001 | 1139 | 0.120 |
Why?
|
| Neutrophils | 1 | 2007 | 3779 | 0.120 |
Why?
|
| Streptococcal Infections | 1 | 1999 | 618 | 0.110 |
Why?
|
| Plethysmography, Impedance | 2 | 1990 | 44 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2008 | 2441 | 0.110 |
Why?
|
| Cardiography, Impedance | 2 | 1990 | 40 | 0.110 |
Why?
|
| Hypnotics and Sedatives | 1 | 2001 | 1193 | 0.100 |
Why?
|
| Thoracic Diseases | 1 | 1993 | 99 | 0.100 |
Why?
|
| Coronary Vessel Anomalies | 1 | 1996 | 308 | 0.100 |
Why?
|
| Lithotripsy | 2 | 1993 | 137 | 0.100 |
Why?
|
| Pain Measurement | 3 | 2010 | 3584 | 0.100 |
Why?
|
| Analgesics, Opioid | 3 | 2008 | 3837 | 0.100 |
Why?
|
| Bacteremia | 1 | 1999 | 983 | 0.100 |
Why?
|
| Thoracic Neoplasms | 1 | 1993 | 269 | 0.090 |
Why?
|
| Double-Blind Method | 4 | 2010 | 12451 | 0.090 |
Why?
|
| Hernia, Inguinal | 1 | 1994 | 224 | 0.090 |
Why?
|
| Vasoconstriction | 1 | 1993 | 591 | 0.090 |
Why?
|
| Anesthesia, Spinal | 1 | 1994 | 281 | 0.090 |
Why?
|
| Critical Care | 2 | 2001 | 2714 | 0.090 |
Why?
|
| Respiration Disorders | 1 | 1994 | 364 | 0.090 |
Why?
|
| Intraoperative Complications | 2 | 1995 | 1171 | 0.090 |
Why?
|
| Epinephrine | 1 | 1994 | 782 | 0.090 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 1997 | 996 | 0.080 |
Why?
|
| Surgical Wound Infection | 1 | 1999 | 1547 | 0.080 |
Why?
|
| Microcomputers | 1 | 1989 | 139 | 0.080 |
Why?
|
| Online Systems | 1 | 1989 | 181 | 0.080 |
Why?
|
| Vascular Resistance | 2 | 2007 | 939 | 0.080 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 1989 | 97 | 0.080 |
Why?
|
| Thrombolytic Therapy | 1 | 1997 | 2054 | 0.080 |
Why?
|
| Infection Control | 1 | 2015 | 984 | 0.080 |
Why?
|
| Administration, Cutaneous | 1 | 2010 | 715 | 0.070 |
Why?
|
| Computer Graphics | 1 | 1989 | 345 | 0.070 |
Why?
|
| Endpoint Determination | 1 | 2010 | 592 | 0.070 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 2008 | 145 | 0.070 |
Why?
|
| Behavior | 1 | 2010 | 538 | 0.070 |
Why?
|
| Neuromuscular Blockade | 1 | 2008 | 148 | 0.070 |
Why?
|
| Anesthesia | 2 | 2007 | 1595 | 0.070 |
Why?
|
| Injections, Intravenous | 2 | 2008 | 1377 | 0.070 |
Why?
|
| Anesthetics, Intravenous | 2 | 2002 | 396 | 0.070 |
Why?
|
| Osmolar Concentration | 1 | 2007 | 654 | 0.070 |
Why?
|
| Water-Electrolyte Balance | 1 | 2007 | 326 | 0.070 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2008 | 361 | 0.060 |
Why?
|
| Hematocrit | 1 | 2007 | 622 | 0.060 |
Why?
|
| Anesthesia, General | 2 | 1989 | 1188 | 0.060 |
Why?
|
| Middle Aged | 16 | 2015 | 223233 | 0.060 |
Why?
|
| Child Behavior | 1 | 1990 | 864 | 0.060 |
Why?
|
| Aged | 12 | 2015 | 171319 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 1997 | 2598 | 0.060 |
Why?
|
| Prospective Studies | 5 | 2010 | 54886 | 0.050 |
Why?
|
| Female | 19 | 2015 | 396660 | 0.050 |
Why?
|
| Arousal | 1 | 1989 | 1174 | 0.050 |
Why?
|
| Leukocyte Count | 1 | 2007 | 1606 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2008 | 10748 | 0.050 |
Why?
|
| Monitoring, Physiologic | 2 | 1990 | 1794 | 0.050 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1989 | 1458 | 0.050 |
Why?
|
| Sodium | 1 | 2007 | 1594 | 0.050 |
Why?
|
| Humans | 28 | 2015 | 767040 | 0.050 |
Why?
|
| Male | 15 | 2015 | 364203 | 0.050 |
Why?
|
| Adult | 14 | 2008 | 223317 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 4855 | 0.040 |
Why?
|
| Biological Availability | 1 | 1999 | 387 | 0.040 |
Why?
|
| Pleura | 1 | 2000 | 245 | 0.040 |
Why?
|
| Hemofiltration | 1 | 1999 | 58 | 0.040 |
Why?
|
| Respiration, Artificial | 2 | 2001 | 2726 | 0.040 |
Why?
|
| Multiple Trauma | 1 | 2001 | 369 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2015 | 59548 | 0.040 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 2850 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 2270 | 0.040 |
Why?
|
| Adolescent | 5 | 2010 | 89046 | 0.040 |
Why?
|
| Anesthetics, Inhalation | 1 | 2002 | 573 | 0.040 |
Why?
|
| Injections | 1 | 2000 | 839 | 0.030 |
Why?
|
| Oxygen | 2 | 2007 | 4252 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 2000 | 15824 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1997 | 324 | 0.030 |
Why?
|
| Streptococcus pyogenes | 1 | 1999 | 293 | 0.030 |
Why?
|
| Electroencephalography | 2 | 2002 | 6282 | 0.030 |
Why?
|
| Heart Rate | 2 | 2001 | 4209 | 0.030 |
Why?
|
| Mouth Neoplasms | 1 | 2001 | 597 | 0.030 |
Why?
|
| Dobutamine | 1 | 1996 | 114 | 0.030 |
Why?
|
| Equipment Design | 1 | 2003 | 3489 | 0.030 |
Why?
|
| Anxiety | 1 | 1990 | 4670 | 0.030 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1996 | 177 | 0.030 |
Why?
|
| Pain | 1 | 2010 | 5101 | 0.030 |
Why?
|
| Lung | 1 | 1993 | 10076 | 0.030 |
Why?
|
| Genital Diseases, Female | 1 | 1995 | 192 | 0.030 |
Why?
|
| Alfentanil | 1 | 1993 | 27 | 0.030 |
Why?
|
| Time Factors | 3 | 2008 | 40154 | 0.030 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 1993 | 115 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2010 | 42606 | 0.030 |
Why?
|
| Norepinephrine | 1 | 1996 | 898 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 1996 | 540 | 0.030 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1993 | 277 | 0.030 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 1993 | 94 | 0.020 |
Why?
|
| Fentanyl | 1 | 1996 | 451 | 0.020 |
Why?
|
| Fever | 1 | 1999 | 1605 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1996 | 1097 | 0.020 |
Why?
|
| Stroke Volume | 2 | 1996 | 5618 | 0.020 |
Why?
|
| Thermodilution | 1 | 1990 | 50 | 0.020 |
Why?
|
| Arm | 1 | 1993 | 591 | 0.020 |
Why?
|
| Abdomen | 1 | 1995 | 1138 | 0.020 |
Why?
|
| Syndrome | 1 | 1996 | 3271 | 0.020 |
Why?
|
| Hyperthermia, Induced | 1 | 1993 | 414 | 0.020 |
Why?
|
| Dopamine | 1 | 1996 | 1581 | 0.020 |
Why?
|
| Child | 4 | 2010 | 80771 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2001 | 2513 | 0.020 |
Why?
|
| Aorta | 1 | 1996 | 2045 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 1997 | 2079 | 0.020 |
Why?
|
| Leg | 1 | 1993 | 1087 | 0.020 |
Why?
|
| Blood Pressure | 3 | 1993 | 8531 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1993 | 1493 | 0.020 |
Why?
|
| Problem Solving | 1 | 1989 | 442 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1993 | 1873 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1999 | 4209 | 0.020 |
Why?
|
| Sleep Stages | 1 | 1990 | 705 | 0.020 |
Why?
|
| Infant | 3 | 1996 | 36485 | 0.020 |
Why?
|
| Positive-Pressure Respiration | 1 | 1990 | 713 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 1996 | 2144 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1996 | 3114 | 0.010 |
Why?
|
| Laparoscopy | 1 | 1995 | 2037 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1993 | 1162 | 0.010 |
Why?
|
| Administration, Oral | 1 | 1991 | 4026 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 1993 | 1931 | 0.010 |
Why?
|
| Diazepam | 1 | 2002 | 215 | 0.010 |
Why?
|
| Sarcoma | 1 | 1993 | 1802 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1993 | 4424 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1989 | 3837 | 0.010 |
Why?
|
| Pregnancy | 1 | 1999 | 30238 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2002 | 947 | 0.010 |
Why?
|
| Software | 1 | 1989 | 4472 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1996 | 39317 | 0.010 |
Why?
|
| Melanoma | 1 | 1993 | 5702 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1993 | 247 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1994 | 26396 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1993 | 11872 | 0.010 |
Why?
|
| Melphalan | 1 | 1993 | 421 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1993 | 1479 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 1990 | 512 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1990 | 1623 | 0.000 |
Why?
|
| Cisplatin | 1 | 1993 | 1656 | 0.000 |
Why?
|
| Risk Factors | 1 | 1993 | 74886 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 1990 | 20169 | 0.000 |
Why?
|
| Brain Neoplasms | 1 | 1990 | 9108 | 0.000 |
Why?
|
| Animals | 1 | 1995 | 168965 | 0.000 |
Why?
|
Concepts
(198)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_